전남대학교 중앙도서관

Persistence of immune responses after heterologous and homologous third COVID-19 vaccine dose schedules in the UK: eight-month analyses of the COV-BOOST trial.

학술저널

issue: The Journal of infection [J Infect] 2023 Jul; Vol. 87 (1), pp. 18-26. Date of Electronic Publication: 2023 Apr 20.
Author: Liu X; Oxford Vaccine Group, Department of Paediatrics, University of Oxford, Oxford, UK. Electronic address: xinxue.liu@paediatrics.ox.ac.uk.
Munro APS; NIHR Southampton Clinical Research Facility and Biomedical Research Centre, University Hospital Southampton NHS Foundation Trust, Southampton, UK.
Wright A; Imperial Clinical Trials Unit, Imperial College London, London, UK.
Feng S; Oxford Vaccine Group, Department of Paediatrics, University of Oxford, Oxford, UK.
Janani L; Imperial Clinical Trials Unit, Imperial College London, London, UK.
Aley PK; Oxford Vaccine Group, Department of Paediatrics, University of Oxford, Oxford, UK; NIHR Oxford Biomedical Research Centre, Oxford, UK.
Babbage G; NIHR Southampton Clinical Research Facility and Biomedical Research Centre, University Hospital Southampton NHS Foundation Trust, Southampton, UK.
Baker J; NIHR Southampton Clinical Research Facility and Biomedical Research Centre, University Hospital Southampton NHS Foundation Trust, Southampton, UK; Faculty of Medicine and Institute for Life Sciences, University of Southampton, Southampton, UK.
Baxter D; Stockport NHS Foundation Trust, Stockport, UK.
Bawa T; Department of Infection, Guy's and St Thomas' NHS Foundation Trust, London, UK.
Bula M; NIHR Liverpool Clinical Research Facility, Liverpool, UK.
Cathie K; NIHR Southampton Clinical Research Facility and Biomedical Research Centre, University Hospital Southampton NHS Foundation Trust, Southampton, UK; Faculty of Medicine and Institute for Life Sciences, University of Southampton, Southampton, UK.
Chatterjee K; NIHR Cambridge Clinical Research Facility, Cambridge University Hospitals NHS Foundation Trust, Cambridge, UK.
Dodd K; NIHR Liverpool Clinical Research Facility, Liverpool, UK.
Enever Y; PHARMExcel, Welwyn Garden City, Hertfordshire, UK.
Fox L; Portsmouth Hospitals University NHS Trust, Portsmouth, UK.
Qureshi E; NIHR/Wellcome Clinical Research Facility, University Hospitals Birmingham NHS Foundation Trust, Birmingham, UK.
Goodman AL; Department of Infection, Guy's and St Thomas' NHS Foundation Trust, London, UK; MRC Clinical Trials Unit, University College London, London, UK.
Green CA; NIHR/Wellcome Clinical Research Facility, University Hospitals Birmingham NHS Foundation Trust, Birmingham, UK.
Haughney J; Queen Elizabeth University Hospital, NHS Greater Glasgow & Clyde, Glasgow, UK.
Hicks A; Portsmouth Hospitals University NHS Trust, Portsmouth, UK.
Jones CE; NIHR Southampton Clinical Research Facility and Biomedical Research Centre, University Hospital Southampton NHS Foundation Trust, Southampton, UK; Faculty of Medicine and Institute for Life Sciences, University of Southampton, Southampton, UK.
Kanji N; Oxford Vaccine Group, Department of Paediatrics, University of Oxford, Oxford, UK.
van der Klaauw AA; Wellcome-MRC Institute of Metabolic Science, Department of Clinical Biochemistry, University of Cambridge, Cambridge, UK.
Libri V; NIHR UCLH Clinical Research Facility and NIHR UCLH Biomedical Research Centre, University College London Hospitals NHS Foundation Trust, London, UK.
Llewelyn MJ; University Hospitals Sussex NHS Foundation Trust, Brighton, UK.
Mansfield R; Dorset Research Hub, Bournemouth, UK.
Maallah M; Department of Infectious Diseases and Tropical Medicine, London Northwest University Healthcare, London, UK.
McGregor AC; Department of Infectious Diseases and Tropical Medicine, London Northwest University Healthcare, London, UK.
Minassian AM; Oxford Vaccine Group, Department of Paediatrics, University of Oxford, Oxford, UK; Jenner Institute, Nuffield Department of Medicine, University of Oxford, Oxford, UK.
Moore P; The Adam Practice, Poole, UK.
Mughal M; Stockport NHS Foundation Trust, Stockport, UK.
Mujadidi YF; NIHR Oxford Biomedical Research Centre, Oxford, UK.
Belhadef HT; NIHR Oxford Biomedical Research Centre, Oxford, UK.
Holliday K; NIHR Leeds Clinical Research Facility, Leeds Teaching Hospitals Trust and University of Leeds, Leeds, UK.
Osanlou O; Public Health Wales, Betsi Cadwaladr University Health Board, Bangor University, Bangor, UK.
Osanlou R; University of Liverpool, Liverpool, UK.
Owens DR; NIHR Southampton Clinical Research Facility and Biomedical Research Centre, University Hospital Southampton NHS Foundation Trust, Southampton, UK; Faculty of Medicine and Institute for Life Sciences, University of Southampton, Southampton, UK.
Pacurar M; NIHR Southampton Clinical Research Facility and Biomedical Research Centre, University Hospital Southampton NHS Foundation Trust, Southampton, UK; Faculty of Medicine and Institute for Life Sciences, University of Southampton, Southampton, UK.
Palfreeman A; University Hospitals of Leicester NHS Trust, University of Leicester, Leicester, UK.
Pan D; University Hospitals of Leicester NHS Trust, University of Leicester, Leicester, UK; Department of Respiratory Sciences, University of Leicester, Leicester, UK.
Rampling T; NIHR UCLH Clinical Research Facility and NIHR UCLH Biomedical Research Centre, University College London Hospitals NHS Foundation Trust, London, UK.
Regan K; Oxford Vaccine Group, Department of Paediatrics, University of Oxford, Oxford, UK.
Saich S; NIHR Southampton Clinical Research Facility and Biomedical Research Centre, University Hospital Southampton NHS Foundation Trust, Southampton, UK.
Saralaya D; Bradford Institute for Health Research and Bradford Teaching Hospitals NHS Foundation Trust, Bradford, UK.
Sharma S; University Hospitals Sussex NHS Foundation Trust, Brighton, UK.
Sheridan R; Royal Devon and Exeter Hospital NHS Foundation Trust, Exeter, UK.
Stokes M; NIHR Southampton Clinical Research Facility and Biomedical Research Centre, University Hospital Southampton NHS Foundation Trust, Southampton, UK.
Thomson EC; Queen Elizabeth University Hospital, NHS Greater Glasgow & Clyde, Glasgow, UK; MRC University of Glasgow Centre for Virus Research, Glasgow, UK.
Todd S; Royal Devon and Exeter Hospital NHS Foundation Trust, Exeter, UK.
Twelves C; NIHR Leeds Clinical Research Facility, Leeds Teaching Hospitals Trust and University of Leeds, Leeds, UK.
Read RC; NIHR Southampton Clinical Research Facility and Biomedical Research Centre, University Hospital Southampton NHS Foundation Trust, Southampton, UK; Faculty of Medicine and Institute for Life Sciences, University of Southampton, Southampton, UK.
Charlton S; UK Health Security Agency, Porton Down, UK.
Hallis B; UK Health Security Agency, Porton Down, UK.
Ramsay M; UK Health Security Agency, Colindale, London, UK.
Andrews N; UK Health Security Agency, Colindale, London, UK.
Lambe T; Oxford Vaccine Group, Department of Paediatrics, University of Oxford, Oxford, UK.
Nguyen-Van-Tam JS; Lifespan and Population Health Unit, University of Nottingham School of Medicine, UK.
Cornelius V; Imperial Clinical Trials Unit, Imperial College London, London, UK.
Snape MD; Oxford Vaccine Group, Department of Paediatrics, University of Oxford, Oxford, UK; NIHR Oxford Biomedical Research Centre, Oxford, UK.
Faust SN; NIHR Southampton Clinical Research Facility and Biomedical Research Centre, University Hospital Southampton NHS Foundation Trust, Southampton, UK. Electronic address: s.faust@soton.ac.uk.
DB Label: Database : MEDLINE

원문보기: Full Text (ScienceDirect) Full Text (Clinical Key) 등재 - Web of Science (SCIE) 조회 - Impact Factor (JCR)

링크메뉴

주메뉴

전자자료 상세검색

전자자료 상세검색

전체선택